US Bancorp
TMDX icon

US Bancorp’s Transmedics TMDX Stock Holding History

US Bancorp’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7K Sell
281
-203
-42% -$17.2K ﹤0.01% 3232
2026
Q1 		$48.1K Sell
484
-89
-16% -$11.6K ﹤0.01% 2726
2025
Q4 		$69.7K Buy
573
+40
+8% +$5.02K ﹤0.01% 2547
2025
Q3 		$59.8K Buy
533
+104
+24% +$12.2K ﹤0.01% 2593
2025
Q2 		$57.5K Buy
429
+90
+27% +$9.88K ﹤0.01% 2707
2025
Q1 		$22.8K Sell
339
-66
-16% -$4.54K ﹤0.01% 3112
2024
Q4 		$25.3K Sell
405
-1,600
-80% -$149K ﹤0.01% 3065
2024
Q3 		$315K Buy
2,005
+124
+7% +$19.1K ﹤0.01% 1781
2024
Q2 		$283K Sell
1,881
-361
-16% -$43.3K ﹤0.01% 1815
2024
Q1 		$166K Sell
2,242
-3,366
-60% -$277K ﹤0.01% 2093
2023
Q4 		$443K Buy
5,608
+2,317
+70% +$140K ﹤0.01% 1578
2023
Q3 		$180K Sell
3,291
-2,362
-42% -$170K ﹤0.01% 1882
2023
Q2 		$475K Sell
5,653
-458
-7% -$35.1K ﹤0.01% 1423
2023
Q1 		$463K Buy
6,111
+5,359
+713% +$371K ﹤0.01% 1441
2022
Q4 		$46.4K Buy
752
+612
+437% +$32.5K ﹤0.01% 2574
2022
Q3 		$6K Sell
140
-15,296
-99% -$665K ﹤0.01% 3553
2022
Q2 		$485K Sell
15,436
-20,596
-57% -$549K ﹤0.01% 1465
2022
Q1 		$971K Buy
36,032
+61
+0.2% +$1.09K ﹤0.01% 1197
2021
Q4 		$689K Sell
35,971
-943
-3% -$23.6K ﹤0.01% 1379
2021
Q3 		$1.22M Buy
36,914
+36,864
+73,728% +$1.13M ﹤0.01% 1085
2021
Q2 		$2K Buy
50
+12
+32% +$333 ﹤0.01% 3848
2021
Q1 		$2K Buy
+38
New +$1.17K ﹤0.01% 3733
2020
Q3 		– Sell
-200
Closed -$4K – 3845
2020
Q2 		$4K Buy
+200
New +$3.13K ﹤0.01% 3398

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

US Bancorp's TMDX Position: Q2 2026 in Review

US Bancorp reduced its Transmedics (TMDX) stake by 42% in Q2 2026, selling an estimated $17.2K and leaving 281 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3232.

US Bancorp first reported a position in TMDX in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.22M in Q3 2021. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • US Bancorp held 281 shares of Transmedics worth $18.7K as of Q2 2026.
  • US Bancorp sold 203 Transmedics shares in Q2 2026, an estimated $17.2K.
  • Transmedics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3232 holding.
  • US Bancorp first reported a position in Transmedics in Q2 2020 and has held it in 23 quarters since.
  • US Bancorp's Transmedics position peaked at $1.22M in Q3 2021.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.